Indoor black carbon and biomarkers of systemic inflammation and endothelial activation in COPD patients.
Indoor black carbon and biomarkers of systemic inflammation and endothelial activation in COPD patients.
复制标题
DOI:
10.1016/j.envres.2018.05.010
复制
发表时间:
2018-08
影响因子:
8.3
通讯作者:
Koutrakis P
中科院分区:
文献类型:
--
作者:
Garshick E;Grady ST;Hart JE;Coull BA;Schwartz JD;Laden F;Moy ML;Koutrakis P
Evidence linking traffic-related particle exposure to systemic effects in chronic obstructive lung disease (COPD) patients is limited. Assess relationships between indoor black carbon (BC), a tracer of traffic-related particles, and plasma biomarkers of systemic inflammation and endothelial activation. BC was measured by reflectance in fine particle samples over a mean of 7.6 days in homes of 85 COPD patients up to 4 times seasonally over a year. After the completion of sampling, plasma C-reactive protein (CRP), interleukin-6 (IL-6), and soluble vascular adhesion molecule-1 (sVCAM-1) were measured. Current smokers and homes with major sources of BC were excluded; therefore, indoor BC was primarily a measure of infiltrated outdoor BC. Mixed effects regression models with a random intercept for each participant were used to assess BC effects at different times (1–9 days before phlebotomy) and in the multi-day sample. Measured median BC was 0.19 μg/m3 (interquartile range, IQR=0.22 μg/m3). Adjusting for season, race, age, BMI, heart disease, diabetes, ambient temperature, relative humidity, a recent cold or similar illness, and blood draw time, there was a positive relationship between BC and CRP. The largest effect size was for BC averaged over the previous seven days (11.8% increase in CRP per IQR; 95%CI = 1.8–22.9). Effects were greatest among non-statin users and persons with diabetes. There were positive effects of BC on IL-6 only in non-statin users. There were no associations with sVCAM-1. These results demonstrate exposure-response relationships between indoor BC with biomarkers of systemic inflammation in COPD patients, with stronger relationships in persons not using statins and with diabetes.
登录
查看更多内容
DOI:
10.1097/ede.0b013e31824523f0
发表时间:
2012-03
期刊:
Epidemiology (Cambridge, Mass.)
影响因子:
--
作者:
Bind MA;Baccarelli A;Zanobetti A;Tarantini L;Suh H;Vokonas P;Schwartz J
通讯作者:
Schwartz J
影响因子:
10.4
作者:
Alexeeff SE;Coull BA;Gryparis A;Suh H;Sparrow D;Vokonas PS;Schwartz J
通讯作者:
Schwartz J
影响因子:
10
作者:
Atkinson RW;Kang S;Anderson HR;Mills IC;Walton HA
通讯作者:
Walton HA
影响因子:
11.8
作者:
Grady ST;Koutrakis P;Hart JE;Coull BA;Schwartz J;Laden F;Zhang JJ;Gong J;Moy ML;Garshick E
通讯作者:
Garshick E
影响因子:
10.4
作者:
Delfino, Ralph J.;Staimer, Norbert;Sioutas, Constantinos
通讯作者:
Sioutas, Constantinos